Trade subject to notification - Medi-Stim

15 nov. 2007 03h14 HE | Source: Orkla ASA Orkla ASA

After this transaction Orkla owns 1 500 000 shares in Medi-Stim which is 7.95 % of the share capital.

Ref.:

Rune Helland, SVP Investor Relations, Tel: +47 2254 4411